The botanical extracts sector is getting its M&A moment
After decades in the shadows, India’s botanical extracts industry is beginning to attract serious capital, forcing a shift from small, family-owned trading houses to professionally run, acquisition-led platforms.
India’s botanical extracts sector is shifting from a fragmented, family-run trading business to a capital-backed, M&A-led industry
Venture-backed players like Botanic Healthcare, Zeus Hygia and Ingex Botanicals are driving consolidation and professionalising R&D
Valuations have reset sharply, with quality platforms now commanding 8–10x EBITDA versus 3–4x earlier
Higher margins lie in clinically validated, food-compatible ingredients, making consolidation inevitable
Small, science-led firms built around single molecules or academic research are emerging as prime acquisition targets, as they lack scale but offer IP and differentiation
Anuj Suvarna